Published in J Physiol on July 01, 1968
Histamine in the regulation of wakefulness. Sleep Med Rev (2010) 1.05
Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol (1991) 0.97
Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey. J Sleep Res (2011) 0.86
Rat brain amines, blood histamine and glucose levels in relationship to circadian changes in sleep induced by pentobarbitone sodium. J Physiol (1969) 0.82
Concentrations of histamine in brain of guinea pig and rat during dietary protein malnutrition. Biochem J (1974) 0.79
Regulation of the daily rhythm in tyrosine transaminase activity by environmental factors. Proc Natl Acad Sci U S A (1968) 0.78
The effects of hallucinogenic drugs on maze exploration in the rat over a 24 hour period. Br J Pharmacol (1973) 0.76
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
Human circadian rhythms. Physiol Rev (1966) 3.44
The effect of histamine on an isolated sympathetic ganglion. J Mt Sinai Hosp N Y (1952) 2.28
Photic and neural control of the 24-hour norepinephrine rhythm in the rat pineal gland. J Pharmacol Exp Ther (1967) 1.11
Action of histamine on the jugular venous pressure and cerebral circulation of the dog; effects of antihistaminic drugs (pyrilamine and chlorpheniramine) and a histamine liberating agent (48/80 B.W.). J Pharmacol Exp Ther (1956) 1.06
Circadian rhythm for tryptophan pyrrolase activity and its circulating substrate. Science (1966) 1.04
Circadian pattern of plasma 17-hydroxycorticosteroid: alteration by anticholinergic agents. Science (1967) 1.03
Circadian rhythms of liver enzymes and their relationship to enzyme induction. Science (1967) 1.01
CIRCADIAN RHYTHM IN PINEAL SEROTONIN: EFFECT OF MONOAMINE OXIDASE INHIBITION AND RESERPINE. Science (1965) 0.96
The relation between spontaneous activity, metabolic rate and the 24 hour cycle in mice at different environmental temperatures. J Physiol (1967) 0.96
Mechanism of the EEG-synchronizing action of serotonin. Am J Physiol (1966) 0.96
Slow dark discharge rhythms of cat retinal ganglion cells. J Neurophysiol (1966) 0.94
Effect of light on corticosterone levels in plasma of rats. Am J Physiol (1966) 0.92
CONTROL OF 5-HYDROXYTRYPTOPHAN DECARBOXYLASE ACTIVITY IN THE RAT PINEAL GLAND BY SYMPATHETIC NERVES. J Pharmacol Exp Ther (1965) 0.89
[Electrophysiological actions of stimulants of the central nervous system. I. Adrenergic, cholinergic systems and serotonic neurohumors]. Arch Int Pharmacodyn Ther (1960) 0.89
Daily rhythm in tyrosine concentration in human plasma: persistence on low-protein diets. Science (1967) 0.88
Effect of histamine on ganglionic transmission. Br J Pharmacol Chemother (1959) 0.88
A single extraction method for the determination of both norepinephrine and serotonin in brain. Biochem Pharmacol (1961) 0.88
The waking action of histamine. Experientia (1967) 0.85
Circadian variations in renal excretion of magnesium, calcium, phosphorus, sodium, and potassium during frequent feeding and fasting. Fed Proc (1966) 0.82
Circadian rhythmycity of some key metabolites in the fasted and fed weanling female rat. Experientia (1967) 0.81
Circadian changes in brain 5-hydroxytryptamine and plasma corticosterone in the rat. Life Sci (1967) 0.80
Circadian rhythms in rats: effects of random lighting. Science (1966) 0.79
Anorexigenic activity of L(-) DOPA in animals pretreated with monoaminoxidase inhibitor. Med Exp Int J Exp Med (1961) 0.78
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol (1999) 3.30
PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res (1997) 3.15
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg (1998) 3.11
Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol (1999) 2.69
The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J Gen Virol (1989) 2.64
Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology (1994) 2.51
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol (1998) 2.39
Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol (1978) 2.33
Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol (1987) 2.27
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol (1991) 2.05
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res (1997) 1.89
Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol (1986) 1.87
Pathogenesis of scrapie in mice after intragastric infection. Virus Res (1989) 1.82
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg (1991) 1.81
Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J Comp Pathol (1979) 1.69
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol (1993) 1.62
Alterations of the TP53 gene in human gliomas. Cancer Res (1994) 1.58
Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob Agents Chemother (1986) 1.56
Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology (1993) 1.54
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. Br J Cancer (2009) 1.49
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene (1995) 1.49
Thromboembolic complications after Fontan operations. Circulation (1995) 1.49
Ultrastructure and clinicopathologic correlation of idiopathic preretinal macular fibrosis. Am J Ophthalmol (1975) 1.47
Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J Comp Pathol (1978) 1.45
Pathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS. J Gen Virol (1980) 1.42
Subarachnoid hemorrhage from intracranial dissecting aneurysm. J Neurosurg (1984) 1.39
Giant cavernous hemangioma of the face. Arch Ophthalmol (1994) 1.39
Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol (2001) 1.38
Drusen of the optic disc. A retrospective study in cadaver eyes. Br J Ophthalmol (1975) 1.38
Sensitive bioassay for vancomycin. Antimicrob Agents Chemother (1978) 1.37
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors. Proc Natl Acad Sci U S A (2000) 1.32
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol (1998) 1.32
Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol (1987) 1.25
Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer (1992) 1.24
The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res (1989) 1.22
Drusen of the optic disc. Surv Ophthalmol (1977) 1.21
The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Arch Virol (1983) 1.21
Posterior fossa arteriovenous malformations. J Neurosurg (1986) 1.21
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol (2000) 1.19
Shadow cells in an intracranial dermoid cyst. Arch Pathol Lab Med (1995) 1.18
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats. Clin Cancer Res (2000) 1.17
Failed aneurysm surgery. Reoperation in 115 cases. J Neurosurg (1984) 1.17
Pathogenesis of mouse scrapie: evidence for spread of infection from central to peripheral nervous system. J Gen Virol (1983) 1.17
Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology (1985) 1.15
Plasmids related to RSF1010 from Bordetella bronchiseptica. Plasmid (1986) 1.15
Fiber dissection technique: lateral aspect of the brain. Neurosurgery (2000) 1.13
Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology (1991) 1.13
Diagnosis of phacoanaphylactic endophthalmitis by fine needle aspiration biopsy. Ophthalmic Surg Lasers (1999) 1.12
Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy. Neurology (1997) 1.12
A histopathologic study of retinal arterial aneurysms. Am J Ophthalmol (1978) 1.12
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol (1998) 1.12
Pathogenesis of mouse scrapie. Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve. J Neurol Sci (1984) 1.12
Pathogenesis of mouse scrapie: patterns of agent replication in different parts of the CNS following intraperitoneal infection. J R Soc Med (1982) 1.11
New and emerging pathogens in canine infectious respiratory disease. Vet Pathol (2013) 1.11
Ganglioglioma: a clinical study with long-term follow-up. Surg Neurol (1991) 1.08
Pathogenesis of scrapie: agent multiplication in brain at the first and second passage of hamster scrapie in mice. J Gen Virol (1979) 1.07
Dorsal root entry zone lesions for the treatment of post-herpetic neuralgia. J Neurosurg (1984) 1.07
Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol (1983) 1.07
Subretinal neovascularisation in ocular toxoplasmosis. Br J Ophthalmol (1982) 1.06
Removal of intravitreous cysticerci from the surface of the optic nervehead. A pars plana approach. Arch Ophthalmol (1980) 1.06
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients. Br J Cancer (2012) 1.06
Parasitic lesion of the insula suggesting cerebral sparganosis: case report. Neuroradiology (2000) 1.05
Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma. Clin Neuropathol (2004) 1.04
The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates. Int J Rad Appl Instrum B (1991) 1.04
Incubation periods in six models of intraperitoneally injected scrapie depend mainly on the dynamics of agent replication within the nervous system and not the lymphoreticular system. J Gen Virol (1988) 1.04
Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy. Surv Ophthalmol (1982) 1.03
Mapping of quantitative trait loci on porcine chromosome 4. Anim Genet (1998) 1.02
Ocular penetration of 5-fluorocytosine. Invest Ophthalmol Vis Sci (1978) 1.02
Solitary eosinophilic granuloma invading the clivus of an adult: case report. Neurosurgery (1992) 0.99
Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg (2001) 0.99
Endogenous ocular aspergillosis. Ophthalmologica (1974) 0.99
Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microb Pathog (1987) 0.99
External ocular pigmentation. Int Ophthalmol Clin (1971) 0.99
Drusen of the optic disc. A histopathological study. Trans Ophthalmol Soc U K (1975) 0.99
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol (2001) 0.98
Metastatic carcinoma of the iris. Am J Ophthalmol (1975) 0.98
Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. Neuro Oncol (2000) 0.98
Systemic antiviral drugs used in ophthalmology. Surv Ophthalmol (1992) 0.97
The retinal lesions of the acquired immune deficiency syndrome. Trans Am Ophthalmol Soc (1984) 0.97
Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis. Acta Neuropathol (2000) 0.97
Seizure outcome after temporal lobectomy for temporal lobe epilepsy: a Kaplan-Meier survival analysis. Neurology (2000) 0.97
Transmissible mink encephalopathy (TME) in Chinese hamsters: identification of two strains of TME and comparisons with scrapie. Neuropathol Appl Neurobiol (1986) 0.96
Effects of Listeria monocytogenes hemolysins on the isolated ileum of rabbit. Am J Vet Res (1967) 0.96
Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets. Curr Opin Pediatr (2001) 0.95
Tuberculoma of the choroid. Ophthalmology (1980) 0.95
Identification of quantitative trait loci (QTL) for resistance to Fusarium crown rot (Fusarium pseudograminearum) in multiple assay environments in the Pacific Northwestern US. Theor Appl Genet (2012) 0.95
Exogenous Moraxella liquefaciens endophthalmitis. Ophthalmologica (1975) 0.94
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1. Clin Cancer Res (1999) 0.94
Epithelial implantation membrane on the iris surface following cataract extraction with report of two cases. Am J Ophthalmol (1971) 0.93
Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke. Cancer (1999) 0.93
Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia (1999) 0.93
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report. J Neurooncol (1995) 0.93
Retinal manifestations of the acquired immune deficiency syndrome (AIDS): cytomegalovirus, candida albicans, cryptococcus, toxoplasmosis and Pneumocystis carinii. Trans Ophthalmol Soc U K (1983) 0.92
Unusual chorioretinal degeneration associated with sarcoidosis. Am J Ophthalmol (1988) 0.92
Neurofibromatosis and neural crest neoplasms: primary acquired melanosis and malignant melanoma of the conjunctiva. Surv Ophthalmol (1989) 0.91
Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci (1983) 0.91
Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass. J Thorac Cardiovasc Surg (2001) 0.91
Pathogenesis of experimental scrapie. Ciba Found Symp (1988) 0.90
New findings in the chromosome 13 long-arm deletion syndrome and retinoblastoma. Ophthalmology (1979) 0.90